Use of 18F FDG PET and the short temporal response of Hodgkin's disease to RIT

Radioimmunotherapy (RIT) has been available for some time to treat patients with non-Hodgkin's lymphoma, but its use in Hodgkin's lymphoma has been less available, partly because of the need to find an appropriate antibody. A new radioiodinated chimeric antibody directed against the CD25 e...

Full description

Bibliographic Details
Main Authors: Ewa Nowosinska, Pei San Chan, John R Buscombe
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2018-01-01
Series:World Journal of Nuclear Medicine
Subjects:
Online Access:http://www.wjnm.org/article.asp?issn=1450-1147;year=2018;volume=17;issue=3;spage=171;epage=177;aulast=Nowosinska